99 related articles for article (PubMed ID: 16426968)
1. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication.
Rakic B; Sagan SM; Noestheden M; Bélanger S; Nan X; Evans CL; Xie XS; Pezacki JP
Chem Biol; 2006 Jan; 13(1):23-30. PubMed ID: 16426968
[TBL] [Abstract][Full Text] [Related]
2. Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism.
Lyn RK; Kennedy DC; Sagan SM; Blais DR; Rouleau Y; Pegoraro AF; Xie XS; Stolow A; Pezacki JP
Virology; 2009 Nov; 394(1):130-42. PubMed ID: 19747705
[TBL] [Abstract][Full Text] [Related]
3. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication.
Sagan SM; Rouleau Y; Leggiadro C; Supekova L; Schultz PG; Su AI; Pezacki JP
Biochem Cell Biol; 2006 Feb; 84(1):67-79. PubMed ID: 16462891
[TBL] [Abstract][Full Text] [Related]
4. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Aly HH; Shimotohno K; Hijikata M
Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
[TBL] [Abstract][Full Text] [Related]
5. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
[TBL] [Abstract][Full Text] [Related]
6. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
7. Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis.
Aizaki H; Choi KS; Liu M; Li YJ; Lai MM
J Biomed Sci; 2006 Jul; 13(4):469-80. PubMed ID: 16691359
[TBL] [Abstract][Full Text] [Related]
8. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes.
Xue Q; Ding H; Liu M; Zhao P; Gao J; Ren H; Liu Y; Qi ZT
Arch Virol; 2007; 152(5):955-62. PubMed ID: 17273891
[TBL] [Abstract][Full Text] [Related]
10. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication.
Ando M; Korenaga M; Hino K; Ikeda M; Kato N; Nishina S; Hidaka I; Sakaida I
Liver Int; 2008 Sep; 28(8):1158-66. PubMed ID: 18410284
[TBL] [Abstract][Full Text] [Related]
12. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
13. Potential applications of siRNA in hepatitis C virus therapy.
Smolic R; Volarevic M; Wu CH; Wu GY
Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
[TBL] [Abstract][Full Text] [Related]
14. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression.
Suzuki H; Tamai N; Habu Y; Chang MO; Takaku H
FEBS Lett; 2008 Sep; 582(20):3085-9. PubMed ID: 18692048
[TBL] [Abstract][Full Text] [Related]
15. RNAi expression mediated inhibition of HCV replication.
Hamazaki H; Ujino S; Abe E; Miyano-Kurosaki N; Shimotohno K; Takaku H
Nucleic Acids Symp Ser (Oxf); 2004; (48):307-8. PubMed ID: 17150601
[TBL] [Abstract][Full Text] [Related]
16. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
17. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J
Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527
[TBL] [Abstract][Full Text] [Related]
18. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
[TBL] [Abstract][Full Text] [Related]
20. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening.
Trotard M; Lepère-Douard C; Régeard M; Piquet-Pellorce C; Lavillette D; Cosset FL; Gripon P; Le Seyec J
FASEB J; 2009 Nov; 23(11):3780-9. PubMed ID: 19608626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
